quinazolines has been researched along with lch-7749944 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, M; Guo, Q; Li, F; Peng, H; Wang, J; Wang, Y; Zhang, J; Zhao, D; Zhou, Y | 1 |
1 other study(ies) available for quinazolines and lch-7749944
| Article | Year |
|---|---|
LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells.
Topics: Actin Depolymerizing Factors; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; ErbB Receptors; Humans; Lim Kinases; MAP Kinase Kinase 1; Matrix Metalloproteinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Molecular; Molecular Structure; Neoplasm Invasiveness; p21-Activated Kinases; Protein Conformation; Protein Kinase Inhibitors; Proto-Oncogene Proteins pp60(c-src); Pseudopodia; Quinazolines; Signal Transduction; Stomach Neoplasms; Structure-Activity Relationship; Transfection | 2012 |